Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

596
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
596
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

711
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
711
Introduction to Nonparametric Statistics01:28

Introduction to Nonparametric Statistics

1.7K
Nonparametric statistics offer a powerful alternative to traditional parametric methods, useful when assumptions about the population distribution cannot be made. Unlike parametric tests, which require data to follow a specific distribution with well-defined parameters (such as the mean and standard deviation), nonparametric tests do not require such constraints. This makes them particularly valuable when dealing with small sample sizes, skewed data, or ordinal and categorical variables.
One of...
1.7K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

743
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
743
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

405
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-Step Error-Controlling Classifiers With Application to Cost-Effective Disease Diagnosis.

Statistics in medicine·2026
Same author

Estimating controlled direct treatment effects on pain intensity using structural mean models.

Pain reports·2026
Same author

Factors affecting power in stepped wedge trials when the treatment effect varies with time.

Trials·2026
Same author

Evaluation of the Integration of Genetics and Genomics Into Nursing Practice.

Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing·2025
Same author

Weighted Brier Score - an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration.

Statistics in biosciences·2025
Same author

Adolescent Loneliness Trends and Contextual Correlates Across 38 Countries From 2000 to 2022.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 6, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

16.2K

Nonparametric inference for time-dependent incremental cost-effectiveness ratios.

Laura M Yee1, Kwun Chuen Gary Chan1

  • 1Department of Biostatistics, University of Washington, Seattle, WA, 98195, U.S.A.

Statistics in Medicine
|July 29, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to evaluate the changing cost-effectiveness of medical treatments over time. The nonparametric estimator performs well, offering insights for future cost-effectiveness research.

Keywords:
Fieller bandscost-effectiveness analysisinduced informative censoringnonparametric estimationrandomized clinical trialssurvival analysis

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Related Experiment Videos

Last Updated: Apr 6, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

16.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Area of Science:

  • Health Economics
  • Biostatistics
  • Clinical Trials

Background:

  • Rising healthcare costs necessitate evaluating treatment value beyond just effectiveness.
  • Traditional cost-effectiveness analyses (CEAs) in clinical trials are often static, performed only at study conclusion.
  • Treatment cost-effectiveness can dynamically change throughout a patient's follow-up period.

Purpose of the Study:

  • To develop a novel nonparametric estimator for assessing the incremental cost-effectiveness ratio (ICER) over time.
  • To provide statistical tools, including asymptotic variance and confidence bands, for this dynamic ICER estimation.
  • To validate the proposed methods through simulation and real-world clinical trial data.

Main Methods:

  • Development of a nonparametric statistical estimator for time-varying ICER.
  • Derivation of the estimator's asymptotic variance for statistical inference.
  • Formulation of Fieller-based simultaneous confidence bands for robust estimation.
  • Application to data from the Multicenter Automatic Defibrillator Implantation Trial (MADIT II).

Main Results:

  • Simulation studies confirmed the good performance of the proposed point estimators, variance estimators, and confidence bands.
  • Application to MADIT II data demonstrated the practical utility of the dynamic cost-effectiveness assessment.
  • The estimator showed reliable performance in large sample sizes.

Conclusions:

  • The proposed nonparametric method effectively estimates incremental cost-effectiveness ratios over time.
  • This approach provides a valuable tool for dynamic health economic evaluations in clinical research.
  • The findings support the integration of time-varying cost-effectiveness analysis into future healthcare studies.